Phibro Animal Health | PAHC - Pre Tax Profit


Phibro Animal Health reported $38.62M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Align Technology USD 148.89M 27.71M Mar/2026
ANI Pharmaceuticals USD 31.48M 18.04M Dec/2025
Assertio Holdings USD -2.88M 648K Sep/2024
Aurora Cannabis CAD -1.58M 48.55M Dec/2025
Bristol-Myers Squibb USD 1.47B 1.64B Dec/2025
Canopy Growth CAD -62.26M 60.84M Dec/2025
Corcept Therapeutics USD 9.91M 5.33M Dec/2025
Eli Lilly USD 8.27B 1.03B Dec/2025
Henry Schein USD 150M 17M Mar/2026
Idexx Laboratories USD 355.44M 48.46M Mar/2026
Knight Therapeutics CAD -1.92M 13.69M Sep/2025
Merck USD 3.42B 3.32B Dec/2025
Nektar Therapeutics USD -34.7M 2.35M Dec/2025
Pacira USD 571K 8.95M Dec/2025
Phibro Animal Health USD 38.62M 1.26M Dec/2025
Prestige Brands USD 61.81M 7.32M Dec/2025
Supernus Pharmaceuticals USD -5.95M 4.04M Mar/2026
Zoetis USD 761M 126M Dec/2025